FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2865707913> ?p ?o ?g. }

• W2865707913 endingPage "205" @default.
• W2865707913 startingPage "205" @default.
• W2865707913 abstract "Background: Venous thromboembolism (VTE), ischemic stroke, and myocardial infarction in transgender persons may be related to hormone use. Objective: To examine the incidence of these events in a cohort of transgender persons. Design: Electronic medical record–based cohort study of transgender members of integrated health care systems who had an index date (first evidence of transgender status) from 2006 through 2014. Ten male and 10 female cisgender enrollees were matched to each transgender participant by year of birth, race/ethnicity, study site, and index date enrollment. Setting: Kaiser Permanente in Georgia and northern and southern California. Patients: 2842 transfeminine and 2118 transmasculine members with a mean follow-up of 4.0 and 3.6 years, respectively, matched to 48 686 cisgender men and 48 775 cisgender women. Measurements: VTE, ischemic stroke, and myocardial infarction events ascertained from diagnostic codes through the end of 2016 in transgender and reference cohorts. Results: Transfeminine participants had a higher incidence of VTE, with 2- and 8-year risk differences of 4.1 (95% CI, 1.6 to 6.7) and 16.7 (CI, 6.4 to 27.5) per 1000 persons relative to cisgender men and 3.4 (CI, 1.1 to 5.6) and 13.7 (CI, 4.1 to 22.7) relative to cisgender women. The overall analyses for ischemic stroke and myocardial infarction demonstrated similar incidence across groups. More pronounced differences for VTE and ischemic stroke were observed among transfeminine participants who initiated hormone therapy during follow-up. The evidence was insufficient to allow conclusions regarding risk among transmasculine participants. Limitation: Inability to determine which transgender members received hormones elsewhere. Conclusion: The patterns of increases in VTE and ischemic stroke rates among transfeminine persons are not consistent with those observed in cisgender women. These results may indicate the need for long-term vigilance in identifying vascular side effects of cross-sex estrogen. Primary Funding Source: Patient-Centered Outcomes Research Institute and Eunice Kennedy Shriver National Institute of Child Health and Human Development." @default.
• W2865707913 created "2018-07-19" @default.
• W2865707913 creator A5004064950 @default.
• W2865707913 creator A5004958509 @default.
• W2865707913 creator A5004977265 @default.
• W2865707913 creator A5008734895 @default.
• W2865707913 creator A5019092501 @default.
• W2865707913 creator A5034360127 @default.
• W2865707913 creator A5039413618 @default.
• W2865707913 creator A5044873370 @default.
• W2865707913 creator A5049036912 @default.
• W2865707913 creator A5053097927 @default.
• W2865707913 creator A5058543746 @default.
• W2865707913 creator A5059147248 @default.
• W2865707913 creator A5069997688 @default.
• W2865707913 creator A5076277051 @default.
• W2865707913 creator A5078768684 @default.
• W2865707913 creator A5082815773 @default.
• W2865707913 creator A5088838308 @default.
• W2865707913 date "2018-07-10" @default.
• W2865707913 modified "2023-10-16" @default.
• W2865707913 title "Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons" @default.
• W2865707913 cites W1479924026 @default.
• W2865707913 cites W1505423342 @default.
• W2865707913 cites W1545179064 @default.
• W2865707913 cites W1586699954 @default.
• W2865707913 cites W1593442063 @default.
• W2865707913 cites W1604981007 @default.
• W2865707913 cites W1980954492 @default.
• W2865707913 cites W1992439981 @default.
• W2865707913 cites W2000601121 @default.
• W2865707913 cites W2000836832 @default.
• W2865707913 cites W2051578102 @default.
• W2865707913 cites W2073031659 @default.
• W2865707913 cites W2073208821 @default.
• W2865707913 cites W2084792697 @default.
• W2865707913 cites W2085780412 @default.
• W2865707913 cites W2091935032 @default.
• W2865707913 cites W2103732396 @default.
• W2865707913 cites W2118379947 @default.
• W2865707913 cites W2153062627 @default.
• W2865707913 cites W2165873164 @default.
• W2865707913 cites W2231904510 @default.
• W2865707913 cites W2265734805 @default.
• W2865707913 cites W2337642549 @default.
• W2865707913 cites W2542523441 @default.
• W2865707913 cites W2735301415 @default.
• W2865707913 cites W2737493367 @default.
• W2865707913 cites W2754833543 @default.
• W2865707913 cites W2756092087 @default.
• W2865707913 cites W2779947249 @default.
• W2865707913 cites W4241043190 @default.
• W2865707913 cites W4296141746 @default.
• W2865707913 doi "https://doi.org/10.7326/m17-2785" @default.
• W2865707913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6636681" @default.
• W2865707913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29987313" @default.
• W2865707913 hasPublicationYear "2018" @default.
• W2865707913 type Work @default.
• W2865707913 sameAs 2865707913 @default.
• W2865707913 citedByCount "247" @default.
• W2865707913 countsByYear W28657079132018 @default.
• W2865707913 countsByYear W28657079132019 @default.
• W2865707913 countsByYear W28657079132020 @default.
• W2865707913 countsByYear W28657079132021 @default.
• W2865707913 countsByYear W28657079132022 @default.
• W2865707913 countsByYear W28657079132023 @default.
• W2865707913 crossrefType "journal-article" @default.
• W2865707913 hasAuthorship W2865707913A5004064950 @default.
• W2865707913 hasAuthorship W2865707913A5004958509 @default.
• W2865707913 hasAuthorship W2865707913A5004977265 @default.
• W2865707913 hasAuthorship W2865707913A5008734895 @default.
• W2865707913 hasAuthorship W2865707913A5019092501 @default.
• W2865707913 hasAuthorship W2865707913A5034360127 @default.
• W2865707913 hasAuthorship W2865707913A5039413618 @default.
• W2865707913 hasAuthorship W2865707913A5044873370 @default.
• W2865707913 hasAuthorship W2865707913A5049036912 @default.
• W2865707913 hasAuthorship W2865707913A5053097927 @default.
• W2865707913 hasAuthorship W2865707913A5058543746 @default.
• W2865707913 hasAuthorship W2865707913A5059147248 @default.
• W2865707913 hasAuthorship W2865707913A5069997688 @default.
• W2865707913 hasAuthorship W2865707913A5076277051 @default.
• W2865707913 hasAuthorship W2865707913A5078768684 @default.
• W2865707913 hasAuthorship W2865707913A5082815773 @default.
• W2865707913 hasAuthorship W2865707913A5088838308 @default.
• W2865707913 hasBestOaLocation W28657079132 @default.
• W2865707913 hasConcept C11171543 @default.
• W2865707913 hasConcept C120665830 @default.
• W2865707913 hasConcept C121332964 @default.
• W2865707913 hasConcept C126322002 @default.
• W2865707913 hasConcept C127413603 @default.
• W2865707913 hasConcept C144024400 @default.
• W2865707913 hasConcept C149923435 @default.
• W2865707913 hasConcept C15744967 @default.
• W2865707913 hasConcept C1862650 @default.
• W2865707913 hasConcept C201903717 @default.
• W2865707913 hasConcept C2779671885 @default.
• W2865707913 hasConcept C2780645631 @default.
• W2865707913 hasConcept C500558357 @default.

• next